Media Contact

Larissa Doucette

Food and Drug Administration (FDA) has issued five draft documents related to drug compounding and repackaging requirements under the Drug Quality and Security Act (DQSA). The draft documents are applicable to pharmacies, federal facilities, outsourcing facilities, and physicians and are as follows.

The draft guidance documents will be available for public comment for 90 days, and the comment period for the draft memorandum will be open for 120 days. Additional information on the release of these documents is available in a press release on the FDA website.